|

SOC+ BSB-2002 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BlueSphere Bio, Inc1

Indications

  • AML With Mutated NPM11
  • AML, Adult Recurrent1
  • AML - Acute Myeloid Leukemia1
  • Cancer1

St Louis, Missouri1 trial

Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation

Washington University at St Louis

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.